Regen BioPharma Changes Independent Accountant

Ticker: RGBPP · Form: 8-K · Filed: May 29, 2024 · CIK: 1589150

Regen Biopharma INC 8-K Filing Summary
FieldDetail
CompanyRegen Biopharma INC (RGBPP)
Form Type8-K
Filed DateMay 29, 2024
Risk Levelmedium
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: auditor-change, accounting

TL;DR

Regen BioPharma just fired BDO USA, LLP as their auditor and is getting a new one.

AI Summary

Regen BioPharma Inc. announced on May 28, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered public accounting firm, BDO USA, LLP, and has appointed a new firm, which is not yet named in this filing. This change is effective as of May 29, 2024.

Why It Matters

A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors should monitor.

Risk Assessment

Risk Level: medium — Changes in auditors can sometimes precede or coincide with financial reporting issues or strategic shifts, warranting closer investor scrutiny.

Key Players & Entities

FAQ

Who is the new certifying accountant for Regen BioPharma Inc.?

The filing states that Regen BioPharma Inc. has appointed a new independent registered public accounting firm, but the name of this new firm is not disclosed in this particular 8-K filing.

When was the change in certifying accountant effective?

The change in the certifying accountant for Regen BioPharma Inc. is effective as of May 29, 2024.

Was there any disagreement with the former accountant, BDO USA, LLP?

The filing does not mention any disagreements with the former accountant, BDO USA, LLP. It states that the dismissal was not the result of any disagreement.

What is the primary business of Regen BioPharma Inc.?

Regen BioPharma Inc. is classified under the Pharmaceutical Preparations industry (SIC code 2834).

In which state is Regen BioPharma Inc. incorporated?

Regen BioPharma Inc. is incorporated in Nevada.

Filing Stats: 386 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2024-05-29 13:11:22

Filing Documents

01 Changes in Registrant's

Item 4.01 Changes in Registrant's Certifying Accountant. On May 28, 2024 the Board of Directors of Regen Biopharma, Inc. ( the "Registrant"), acting as the Registrant's Audit Committee, approved the engagement of Bush and Associates CPA LLC ("Bush") as its independent auditor. On same date, the accounting firm of Bush was engaged as the Registrant's new independent registered public accounting firm. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REGEN BIOPHARMA, INC. Dated: May 29, 2024 By: /s/ David Koos 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing